pyridinoline

Subscribe to Selected New Research on pyridinoline

523 relevant articles (17 outcomes, 67 trials/studies) found for this Bio-Agent

Description: 3-hydroxypyridinium derivative collagen crosslink; structure

Also Known As:

hydroxylysyl pyridinoline; hydroxylysylpyridinoline; Pyridinium, 4-(2-amino-2-carboxyethyl)-1-(5-amino-5-carboxy-2-hydroxypentyl)-3-(3-amino-3-carboxypropyl)-5-hydroxy-, hydroxide, inner salt

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Amino Acids: 8786

pyridinoline: 523

Experts

1.	Suzuki, Katsuo: 2 articles (06/2005 - 12/2003)
2.	Yokoyama, Toshihiko: 2 articles (06/2005 - 12/2003)
3.	Kume, Mitsuyoshi: 2 articles (06/2005 - 12/2003)
4.	Ito, Genshi: 2 articles (06/2005 - 12/2003)
5.	Yamamoto, Masashi: 2 articles (06/2005 - 12/2003)
6.	Maeda, Masao: 2 articles (06/2005 - 12/2003)
7.	Sako, Chieko: 2 articles (06/2005 - 12/2003)
8.	Shima, Kouichiro: 2 articles (06/2005 - 12/2003)
9.	Rovenský, J: 2 articles (09/2001 - 02/2001)
10.	Istok, R: 2 articles (09/2001 - 02/2001)

Related Diseases

1.	Bone Resorption 11/01/1992 - "The method shows considerable promise as a rapid and specific index of human bone resorption rates, with greatly improved specificity and convenience over total pyridinoline analysis. " 11/24/2000 - "Femur weights and serum concentrations of pyridinoline, a reliable marker of bone resorption, were measured at the end of the study period. " 08/01/2002 - "Bone resorption was assessed by measuring the urinary concentrations of pyridinoline and deoxypiridinoline. " 05/01/2002 - "High levels of urinary pyridinoline crosslinks in the oim/oim;Tg/Tg mice were present at all ages, reflecting continuing high bone resorption. " 03/01/2002 - "3. Plasma pyridinoline concentration was higher in hens in the low BI line, suggesting a greater rate of bone resorption in this line. " Order ALL the reference details at left...
2.	Prostatic Neoplasms (Prostate Cancer) 02/01/1997 - "CONCLUSIONS: Pyridinoline cross-linked carboxyterminal telopeptide might assist PSA and bone scintigraphy in monitoring metastatic bone activity of prostatic cancer." 08/01/1998 - "Also, urinary pyridinoline and deoxypyridinoline were compared in 2 groups of patients with metastatic prostate cancer of the bone who demonstrated progression or positive response to treatment. " 11/01/1996 - "Also, urinary pyridinoline and deoxypyridinoline were compared in 2 groups of patients with metastatic prostate cancer of the bone who demonstrated progression or positive response to treatment. " 09/01/2001 - "Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer." 08/01/1998 - "Measurement of urinary pyridinoline and deoxypyridinoline may provide a useful marker of prostate cancer metastatic to bone and may be useful in monitoring the response to treatment." Order ALL the reference details at left...
3.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/01/1998 - "Levels of urinary pyridinoline and deoxypyridinoline in urine in patients with bony metastatic prostate cancer were significantly greater than levels in patients with benign prostatic hyperplasia or localized prostate cancer. " 04/01/1994 - "Urinary excretion of pyridinoline and deoxypyridinoline was significantly greater in patients with metastatic carcinoma of the prostate compared with patients with either benign prostatic hyperplasia (Mann-Whitney-Wilcoxon rank sum analysis, p < 0.00004 and 0.002, respectively) or localized prostate cancer (Mann-Whitney-Wilcoxon, p < 0.00001 and 0.00005, respectively). " 08/01/1998 - "Urinary pyridinoline and deoxypyridinoline were measured in patients with benign prostatic hyperplasia, clinically localized prostate cancer and prostate cancer with bone metastases. " 11/01/1996 - "RESULTS: Levels of pyridinoline and deoxypyridinoline in urine, and the level of alkaline phosphatase in serum from patients with bone metastatic prostate cancer were significantly greater than levels in patients with benign prostatic hyperplasia or localized prostate cancer. " 11/01/1997 - "METHODS: Serum concentrations of the carboxyterminal propeptide of Type I procollagen (PICP), the carboxyterminal pyridinoline cross-linked telopeptide of Type I collagen (ICTP), and prostate specific antigen (PSA) were measured by radioimmunoassays in 48 patients with benign prostatic hyperplasia (BPH), 25 patients with prostate carcinoma (PCA) without bone metastases, and 36 patients with PCA and bone metastases. " Order ALL the reference details at left...
4.	Neoplasm Metastasis (Metastasis) 02/01/1997 - "Pyridinoline cross-linked carboxyterminal telopeptide, an osteoclastic marker, reflected the extent of bone metastasis more accurately than PSA and other bone markers. " 07/01/1996 - "The aim of this study was to evaluate the urinary pyridinium crosslink levels in breast cancer with or without osseous involvement, and to correlate it with serial doses of CA 15-3. 285 breast cancer patients (226 free of disease and 59 with bone metastases) were measured for both pyridinoline and CA 15-3. In the metastatic patients the mean values of the two markers were significantly higher than in non evident disease patients (P = < 0.01 and p = < 0.001 respectively). " 01/01/2003 - "The efficacy of a serum carboxyterminal pyridinoline cross-linked telopeptide of type I collagen as a quantitative screening marker for bone metastases in patients with urological malignancies." 12/01/1997 - "Levels of urine pyridinoline (U-Pyr) excretion and serum carboxy-terminal propeptide of type 1 procollagen (P1CP) in patients with bone metastasis were significantly higher than those in patients without bone metastasis (P < 0.05). " 02/01/1997 - "During the observation periods, no metastatic bone lesion developed and no significant changes in pyridinoline and deoxypyridinoline occurred in the five patients without bone metastasis. " Order ALL the reference details at left...
5.	Hypertrophic Cicatrix (Hypertrophic Scar) 03/01/1999 - "There is evidence that immunological and biochemical changes are associated with thermal injury, including pyridinoline crosslinks which are present in large quantities in hypertrophic scar, but the primary cause of hypertrophic scar formation still remains to be established. " 09/01/1996 - "It is hypothesised that the occurrence of increased pyridinoline cross-links in hypertrophic scar tissue may result from free radical generation related to inflammatory processes. " 03/01/1979 - "In this investigation, we examined the content of pyridinoline in human normal skin, mature scar and hypertrophic scar. " 09/01/1996 - "Study of free iron and pyridinoline in hypertrophic scars and normal skin." 04/01/2004 - "An increased amount of pyridinoline cross-links per collagen molecule was observed in skin and hypertrophic scar tissue, in combination with increased amounts of collagen. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	deoxypyridinoline
2.	Alkaline Phosphatase
3.	Collagen Type I (Type I Collagen)
4.	Osteocalcin
5.	Biological Markers (Surrogate Marker)
6.	Calcium
7.	Collagen
8.	Hydroxyproline (4 Hydroxyproline)
9.	pamidronate (APD)
10.	Phosphorus

Related Therapies and Procedures

1.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
2.	Ovariectomy (Oophorectomy)
3.	Transplants (Transplant)
4.	Continuous Ambulatory Peritoneal Dialysis (CAPD)
5.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)

Best Treatments:
Research Summary Report
on Bone Resorption

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 292 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>